跳至主要内容
临床试验/NL-OMON43332
NL-OMON43332已完成不适用

The effects of acetylsalicylic acid on immunoparalysis following human endotoxemia - SALYCENDO-study

Radboud Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Written informed consent
  • - Age *18 and *35 yrs
  • - Healthy (as confirmed by medical history, examination, ECG, blood sampling)

排除标准

  • * Use of any medication
  • * Use of COX inhibitors within 6 weeks prior to the first endotoxemia day
  • * Known anaphylaxis or hypersensitivity to acetylsalicylic acid or non-investigational products
  • * History or signs of atopic syndrome (asthma, rhinitis with medication and/or eczema)
  • * History of peptic ulcer disease
  • * History or signs of hematological disease
  • * Thrombocytopenia (<150*10^9/ml) or anemia (hemoglobin < 8.0 mmol/L)
  • * History of glucose-6-phospate dehydrogenase deficiency
  • * History of intracranial hemorrhage
  • * History, signs or symptoms of cardiovascular disease, in particular:
  • * Previous spontaneous vagal collapse
  • * History of atrial or ventricular arrhythmia
  • * Cardiac conduction abnormalities on the ECG consisting of a 2nd degree atrioventricular block or a complete left bundle branch block
  • * Hypertension (defined as RR systolic > 160 or RR diastolic > 90)
  • * Hypotension (defined as RR systolic < 100 or RR diastolic < 50)
  • * Renal impairment (defined as plasma creatinine >120 *mol/l)
  • * Liver enzyme abnormalities (above 2x the upper limit of normal)
  • * Medical history of any disease associated with immune deficiency
  • * CRP > 20 mg/L, WBC > 12x109/L or < 4 x109/L or clinically significant acute illness, including infections, within 4 weeks before the first endotoxemia day
  • * Previous (participation in a study with) LPS administration
  • * Participation in a drug trial or donation of blood 3 months prior to first endotoxemia day
  • * Any vaccination within 3 months prior to first endotoxemia day until the end of the study
  • * Recent hospital admission or surgery with general anesthesia (<3 months to endotoxemia day)
  • * Use of recreational drugs within 21 days prior to the first endotoxemia day
  • * Inability to personally provide written informed consent (e.g. for linguistic or mental reasons) and/or take part in the study

研究者

相似试验